Learn About Depression in the Setting of Chronic Medical Conditions

OSUWexnerbloglogo2014 Learn About Depression in the Setting of Chronic Medical Conditions. More choices in depression management means more decisions to make in depression management. And more decisions can create a conundrum for physicians. On this CME webcast, we are going to help you navigate the often confusing challenge of treating depression in patients with medical illness. Joining us today is Assistant Professor of Psychiatry, Dr. Kevin Johns.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTANDING how depression impacts other medical conditions; and UNDERSTANDING how to diagnose and treat depression in patients with chronic medical problems.

You’ll also learn about the following:

  • Depression in medical illness
  • Whether the choice of anti-depressant matters

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Understanding the Management of Depression

OSUWexnerbloglogo2014 Understanding the Management of Depression. We now have more and better medications to treat depression than the anti-tuberculosis drug created in the 1950’s. We also have much better ways to screen and identify patients with depression. We’re pleased to welcome our guests today to tell us about depression in primary care. Dr. Nazhat Taj-Schaal is an Assistant Professor of Internal Medicine in the Division of General Internal Medicine and Kelli Barnes is a pharmacist and Assistant Professor in the College of Pharmacy.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW recent updated clinical guidelines that address screening for depression, monitoring treatment effects, and integration of behavioral health into primary care; and REVIEW medication treatment options, their unique characteristics and how to choose between different therapies.

You’ll also learn about the following:

  • Epidemiology of depression
  • Different antidepressants have different properties
  • Managing depressed patients in a busy primary care practice
  • Identifying the suicidal patient
  • Practical approach to antidepressant selection
  • Setting realistic expectations for antidepressant effects

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education for Multiple Sclerosis

OSUWexnerbloglogo2014 On-line Education for Multiple Sclerosis. In the 1950’s and 1960’s, almost everyone in America knew Annette Funicello and when she died, it was like a member of everyone’s family died. Hearing about her illness makes us all too cognizant of just how bad MS can be. There has been an enormous change in the way that we treat multiple sclerosis since Annette Funicello was first diagnosed with it 25 years ago and on this CME webcast, we’re going to hear about the breakthroughs that are offering hope to people who a generation ago would not have had the luxury of hope. Joining our moderator, Dr. Jim Allen, in the studio are two of Ohio State University’s experts in MS. First, we have Dr. Jacqueline Nicholas who is an Assistant Professor of Neurology and second we have Dr. Aaron Boster who is also an Assistant Professor of Neurology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the neurological symptoms that should raise clinical suspicion of a diagnosis of multiple sclerosis; INITIATE prompt referral to a neurologist in patients presenting with symptoms that may be indicative of a diagnosis of multiple sclerosis; ESTABLISH a communication strategy with the treating neurologist to discuss treatment, side effects, and barriers to adherence in patients with multiple sclerosis.

You’ll also learn about the following:

  • Challenges in diagnosis of multiple sclerosis
  • Changes in treatment options for patients with multiple sclerosis
  • Management of depression in patients with multiple sclerosis
  • Deep brain stimulation in multiple sclerosis
  • Heredity and multiple sclerosis
  • Management of multiple sclerosis in children
  • Natural history of multiple sclerosis
  • Exercise and multiple sclerosis
  • Diet and multiple sclerosis
  • Sexual dysfunction in multiple sclerosis
  • Urinary dysfunction in multiple sclerosis
  • Spasticity
  • Role of corticosteroids in managing multiple sclerosis

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.